[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,249
  • Shares Outstanding, K 13,649
  • Annual Sales, $ 1,730 K
  • Annual Income, $ -23,360 K
  • EBIT $ -19 M
  • EBITDA $ -16 M
  • 60-Month Beta 1.16
  • Price/Sales 3.09
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.40
  • Most Recent Earnings $-0.78 on 08/13/26
  • Next Earnings Date 11/12/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 456.91% (+75.78%)
  • Historical Volatility 88.88%
  • IV Percentile 40%
  • IV Rank 27.59%
  • IV High 1,285.20% on 02/04/26
  • IV Low 141.29% on 05/21/26
  • Expected Move (DTE 23) 1.8785 (553.80%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 83
  • Volume Avg (30-Day) 36
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 2,086
  • Open Int (30-Day) 1,833
  • Expected Range 0.0000 to 2.2177

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.69
  • Number of Estimates 2
  • High Estimate $-0.60
  • Low Estimate $-0.78
  • Prior Year $-0.80
  • Growth Rate Est. (year over year) +13.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3269 +3.76%
on 08/26/26
1.0100 -66.42%
on 07/27/26
-0.6608 (-66.08%)
since 07/24/26
3-Month
0.3269 +3.76%
on 08/26/26
3.1200 -89.13%
on 05/27/26
-2.6008 (-88.46%)
since 05/26/26
52-Week
0.3269 +3.76%
on 08/26/26
14.8000 -97.71%
on 09/30/25
-12.8608 (-97.43%)
since 08/26/25

Most Recent Stories

More News
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets

112% H1 Revenue Growth, Advance Toward $5 Million Veterinary Milestone, Newly Announced Collaboration and Active Licensing Discussions with More Than a Dozen Global Diagnostic Leaders

VNRX : 0.3392 (-11.80%)
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis

Published in Critical Care Medicine , findings confirm high-predictive accuracy for severe sepsis outcomes, driving commercial momentum across Volition's $2.8 billion addressable market.

VNRX : 0.3392 (-11.80%)
VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for

VNRX : 0.3392 (-11.80%)
Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

Removes Centralized Lab Dependency for $3.8 Billion Global Addressable Market for

VNRX : 0.3392 (-11.80%)
VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update

Conference call to take place on Friday, August 14 at 8:30 a.m. U.S Eastern Time

VNRX : 0.3392 (-11.80%)
Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology

HENDERSON, Nev. , Aug. 5, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, was the first to demonstrate the isolation and analysis...

VNRX : 0.3392 (-11.80%)
Volition Advances Nu.Q® NETs Platform Towards Commercialization

Consistent international data positions Nu.Q® H3.1 as a potential "game changer" in sepsis management within a $3.8 billion addressable market

VNRX : 0.3392 (-11.80%)
VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test

HENDERSON, Nev. , July 7, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the release of a new clinical study demonstrating...

VNRX : 0.3392 (-11.80%)
VolitionRx Announces Collaboration with Sysmex

HENDERSON, Nev. , June 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration with Sysmex ( TYO: 6869 ...

VNRX : 0.3392 (-11.80%)
VolitionRx Announces Pricing of $4.6 Million Public Offering

$4.6 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the full exercise of warrants

VNRX : 0.3392 (-11.80%)

Business Summary

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer...

See More

Key Turning Points

3rd Resistance Point 0.5716
2nd Resistance Point 0.5202
1st Resistance Point 0.4297
Last Price 0.3392
1st Support Level 0.2878
2nd Support Level 0.2364
3rd Support Level 0.1459

See More

52-Week High 14.8000
Fibonacci 61.8% 9.2713
Fibonacci 50% 7.5634
Fibonacci 38.2% 5.8556
Last Price 0.3392
52-Week Low 0.3269

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.